Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 90Neoplasms, Plasma Cell 28Central Nervous System Neoplasms 11Recurrence 10Glioblastoma 10Neoplasms 9Carcinoma, Hepatocellular 9Brain Neoplasms 9Gliosarcoma 8Melanoma 6Lung Neoplasms 6Leukemia 6Glioma 6Carcinoma, Non-Small-Cell Lung 6Waldenstrom Macroglobulinemia 5Prostatic Neoplasms 5Lymphoma, Mantle-Cell 5Myeloproliferative Disorders 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Immunoglobulin Light-chain Amyloidosis 4Colorectal Neoplasms 4Carcinoma, Renal Cell 4Astrocytoma 4Uveal Melanoma 3Oligodendroglioma 3Neuroblastoma 3Myelodysplastic-Myeloproliferative Diseases 3Myelodysplastic Syndromes 3Medulloblastoma 3

Interventions

Dexamethasone 36Aprepitant 31Palonosetron 27Ondansetron 23Granisetron 14fosaprepitant 13Calcium Dobesilate 12Olanzapine 11Therapeutics 7ramosetron 6dexamethasone acetate 5Tropisetron 5Doxorubicin 5Cyclophosphamide 5Surveys and Questionnaires 4Metoclopramide 4netupitant, palosentron drug combination 3netupitant 3dolasetron 3dexamethasone 21-phosphate 3Yoga 3Vincristine 3Psychiatric Rehabilitation 3Prochlorperazine 3Lorazepam 3Dronabinol 3Diphenhydramine 3Acupressure 3ginger extract 2Thalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Vomiting × Thalidomide × Clear all
NCT06017284 2023-11-24

PTCA199-5

Fudan University

Phase 3 Recruiting
100 enrolled
Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

NCT02203253 2016-08-24

Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting

China Medical University, China

Phase 3 Completed
642 enrolled

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡